Top

Published in:

Open Access 01-05-2009 | Educational Feature

Hypertension after renal transplantation

Author: Tomáš Seeman

Published in: Pediatric Nephrology | Issue 5/2009

Abstract

Hypertension is a common and serious complication after renal transplantation. It is an important risk factor for graft loss and morbidity and mortality of transplanted children. The etiology of posttransplant hypertension is multifactorial: native kidneys, immunosuppressive therapy, renal-graft artery stenosis, and chronic allograft nephropathy are the most common causes. Blood pressure (BP) in transplanted children should be measured not only by casual BP (CBP) measurement but also regularly by ambulatory BP monitoring (ABPM). The prevalence of posttransplant hypertension ranges between 60% and 90% depending on the method of BP measurement and definition. Left ventricular hypertrophy is a frequent type of end-organ damage in hypertensive children after transplantation (50–80%). All classes of antihypertensive drugs can be used in the treatment of posttransplant hypertension. Hypertension control in transplanted children is poor; only 20–50% of treated children reach normal BP. The reason for this poor control seems to be inadequate antihypertensive therapy, which can be improved by increasing the number of antihypertensive drugs. Improved hypertension control leads to improved long-term graft and patient survival in adults. In children, there is a great potential for antihypertensive treatment that could also result in improved graft and patient survival.

Available only for authorised users

Midtvedt K, Neumayer HH (2000) Management strategies for posttransplant hypertension. Transplantation 70(Suppl 11):SS64–SS69PubMed

Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A (1994) Analysis of hypertension in children post renal transplantation - a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 8:570–573PubMed

Sorof JM, Sullivan EK, Tejani A, Portman RJ (1999) Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report. J Am Soc Nephrol 10:1324–1330PubMed

Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7:158–165PubMed

Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RSC, Geddes CC, Jardine AG (2005) Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant 19:181–192PubMed

Opelz G, Wujciak T, Ritz E; Collaborative Transplant Study (1998) Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53:217–222PubMed

Mange KC, Gizman B, Joffe M, Feldman HI (2000) Arterial hypertension and renal allograft survival. JAMA 283:633–638PubMed

Schwenger V, Zeier M, Ritz E (2001) Hypertension after renal transplantation. Curr Hypertens Rep 5:434–439

Mitsnefes MM, Omoloja A, McEnery PT (2001) Short-term pediatric renal transplant survival: Blood pressure and allograft function. Pediatr Transplant 5:160–165PubMed

10.

Mitsnefes MM, Khoury PR, McEnery PT (2003) Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98–103PubMed

11.

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576

12.

Calzolari A, Giordano U, Matteucci MC, Pastore E, Turchetta A, Rizzoni G, Alpert B (1998) Hypertension in young patients after renal transplantation, ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens 11:497–501PubMed

13.

Mitsnefes MM, Portman RJ (2003) Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant 7:86–92PubMed

14.

Ferraris JR, Ghezzi L, Waisman G, Krmar RT (2007) ABPM vs. office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplant 11:24–30PubMed

15.

Mitsnefes MM, Kimball TR, Daniels SR (2003) Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 18:145–149PubMed

16.

Jacobi J, Rockstroh J, John S, Schreiber M, Schlaich MP, Neumayer HH, Schmieder RE (2000) Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation 70:819–827PubMed

17.

Bald M, Bohm W, Feldhoff C, Bonzel KE (2001) Home blood pressure self-measurement in children and adolescents with renal replacement therapy. Klin Padiatr 213:21–25PubMed

18.

Wühl E, Hadtstein C, Mehls O, Schaefer F; Escape Trial Group (2004) Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 55:492–497PubMed

19.

Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, Figueras M, Galera J, Serra A, Compliance Group of the Spanish Society of Hypertension (2006) Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens 24:169–175PubMed

20.

Nagasako SS, Koch Nogueira PC, Machado PGP (2003) Arterial hypertension following renal transplantation in children - a short-term study. Pediatr Nephrol 18:1270–1274PubMed

21.

Lingens N, Dobos E, Witte K, Busch C, Lemmer B, Klaus G, Schärer K (1997) Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol 11:23–26PubMed

22.

Matteucci MC, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G (1999) Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int 56:1566–1570PubMed

23.

Giordano U, Matteucci MC, Calzolari A, Turchetta A, Rizzoni G, Alpert BS (2000) Ambulatory blood pressure monitoring in children with aortic coarctation and kidney transplantation. J Pediatr 136:520–523PubMed

24.

Sorof JM, Poffenbarger T, Portman R (2000) Abnormal 24-hour blood pressure patterns in children after renal transplantation. Am J Kidney Dis 35:681–686PubMed

25.

Morgan H, Khan I, Hashmi A, Hebert D, McCrindle BW, Balfe JW (2001) Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol 16:843–847PubMed

26.

Serdaroglu E, Mir S, Berdelli A (2005) Hypertension and ACE gene insertion/deletion polymorphism in pediatric renal transplant patients. Pediatr Transplant 9:612–617PubMed

27.

Seeman T, Dušek J, Vondrák K, Šimková E, Kreisinger J, Feber J, Janda J (2004) Ambulatory blood pressure monitoring in children after renal transplantation. Transplant Proc 36:1355–1356PubMed

28.

Seeman T, Šimková E, Kreisinger J, Vondrák K, Dušek J, Gilík J, Feber J, Dvorák P, Janda J (2006) Control of hypertension in children after renal transplantation. Pediatr Transplant 10:316–322PubMed

29.

McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, Jones DP (2006) Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr Transplant 10:558–564

30.

Kim HC, Kwon JK, Park SB, Cho WH, Park CH (1998) Hypertension in kidney transplantation recipients: effect on long-term renal allograft survival. Transplant Proc 30:3906–3907PubMed

31.

Ponticelli C, Montagnino G, Aroldi A, Angelini C, Braga M, Tarantino A (1993) Hypertension after renal transplantation. Am J Kidney Dis 5(Suppl 2):73–78

32.

Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, Maresca MC (1993) The role of hypertension as damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis 21(Suppl 1):79–83PubMed

33.

Seeman T, Palyzova D, Dusek J, Janda J (2005) Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr 147:366–371

34.

Morales JM (2002) Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Kidney Int 62(Suppl):S81–87

35.

Lipkin GW, Tucker B, Giles M, Raine AE (1993) Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. J Hypertens 11:439–442PubMed

36.

Gordjani A, Offner G, Hoyer PF, Brodehl J (1990) Hypertension after renal transplantation in patients treated with cyclosporine and azathioprine. Arch Dis Child 65:275–279PubMedPubMedCentral

37.

Tejani A (1983) Post-transplant hypertension and hypertensive encephalopathy in renal allograft recipients. Nephron 34:73–78PubMed

38.

Budde K, Waiser J, Fritsche L (1997) Hypertension in patients after renal transplantation. Transplant Proc 29:209–211PubMed

39.

Pérez Fontán M, Rodríguez-Carmona A, Garcia Falcón T, Fernández Rivera C, Valdés F (1999) Early immunological and nonimmunological predictors of arterial hypertension after renal transplantation. Am J Kidney Dis 33:21–25PubMed

40.

Curtis JJ, Diethelm AG, Jones P, Luke RG, Whelchel JD (1985) Benefits of removal of native kidney in hypertension after renal transplantation. Lancet 2:739–742PubMed

41.

Vanrenterghem Y, Waer M, Christiaens MR, Michielsen P (1992) Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporine. Leuven Collaborative Group for Transplantation. Transpl Int 5(Suppl 1):S35–37PubMed

42.

El-Husseini AA, Foda MA, Shokeir AA, Shebab El-Din AB, Sobh MA, Ghoneim MA (2005) Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: A single center experience. Pediatr Transplant 9:763–769PubMed

43.

Kasiske BL, Ballantyne CM (2002) Cardiovascular risk associated with immunosuppression in renal transplantation. Transplant Rev 16:1–21

44.

Inguli E, Tejani A, Markell M (1993) The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era. Transplantation 55:1029–1033

45.

Hocker B, John U, Plank C, Wuhl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tonshoff B (2004) Successful withdrawal of steroids in pediatrics renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation 78:228–234

46.

Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr (2003) Continued superior outcome with modification and lengthened follow-up of a steroid-avoidance pilot with extended Daclizumab induction in pediatric renal transplantation. Transplantation 76:1331–1339

47.

Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG (1976) Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy. Clin Nephrol 5:123–127PubMed

48.

Broyer M, Guest G, Gagnadoux MF, Beurton D (1987) Hypertension following renal transplantation in children. Pediatr Nephrol 1:16–21PubMed

49.

Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT (1987) Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 43:197–204PubMed

50.

Curtis JJ (1994) Hypertension following kidney transplantation. Am J Kidney Dis 23:471–475PubMed

51.

Büscher R, Vester U, Wingen AM, Hoyer PF (2004) Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol 19:1202–1211PubMed

52.

Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 17:141–149PubMed

53.

Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS; FK506 Kidney Transplant Study Group (1997) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 63:977–983PubMed

54.

Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J (2002) A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years. Transplantation 73:775–782PubMed

55.

Margreiter R (2002) Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomized multicentre study. The European Tacrolimus vs Ciclosporin-Microemulsion Renal Transplantation Study Group. Lancet 359:741–746PubMed

56.

Cheigh JS, Haschemeyer RH, Wang JCL, Riggio RR, Tapia L, Stenzel KH, Rubin AL (1989) Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 2:341–348PubMed

57.

Fernández-Fresnedo G, Palomar R, Escallada R, Martin de Francisco AL, Cotorruelo JG, Zubimendi JA, Sanz de Castro S, Ruiz JC, Rodrigo E, Arias M (2001) Hypertension and long-term renal allograft survival: effect of early glomerular filtration rate. Nephrol Dial Transplant 16(Suppl 1):105–109PubMed

58.

Warholm C, Wilczek H, Pettersson E (1995) Hypertension two years after renal transplantation: causes and consequences. Transpl Int 8:286–292PubMed

59.

Sorof J, Daniels S (2002) Obesity hypertension in children: a problem of epidemic proportions. Hypertension 40:441–447PubMed

60.

Lurbe E, Alvarez V, Liao Y, Tacons J, Cooper R, Cremades B, Torro I, Redon J (1998) The impact of obesity and body fat distribution on ambulatory blood pressure in children and adolescents. Am J Hypertens 11:418–424PubMed

61.

Hanevold CD, Ho PL, Talley L, Mitsnefes MM (2005) Obesity and renal transplant outcome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 115:352–356PubMed

62.

Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B (1999) The effect of body mass index on long-term renal allograft survival. Transplantation 68:1294–1297PubMed

63.

Moreso F, Seron D, Anunciada AI, Hueso M, Ramon JM, Fulladosa X, Gil-Vernet S, Alsina J, Grinyo JM (1998) Recipients body surface area as a predictor of post transplant renal allograft evolution. Transplantation 65:671–676PubMed

64.

Fontaine E, Barthelemy Y, Gagnadoux MF, Cukier J, Broyer M, Beurton D (1994) A review of 72 renal artery stenosis in a series of 715 kidney transplantation in children. Prog Urol 4:193–205PubMed

65.

Fung LC, McLorie GA, Khoury AR, Churchill BM (1995) Donor aortic cuff reduces the rate of anastomotic arterial stenosis in pediatric renal transplantation. J Urol 154:909–913PubMed

66.

Bruno S, Remuzzi G, Ruggenenti P (2004) Transplant renal artery stenosis. J Am Soc Nephrol 15:134–141PubMed

67.

Montagnino G, Tarantino A, Banfi G, Maccario M, Costamagna L, Ponticelli C (2000) Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors. Transpl Int 13:166–168PubMed

68.

Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F (1992) Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 92:375–383PubMed

69.

Berber I, Aydin C, Yigit B, Kara VM, Yildar M, Duzyol C, Turkmen F, Titiz MI, Altaca G (2005) Blood pressure and graft outcome in renal transplantation. Transplant Proc 37:997–998PubMed

70.

Akioka K, Takahara S, Ichikawa S, Yoshimura N, Akiyama T, Ohshima S (2005) Factors predicting long-term graft survival after kidney transplantation: Multicenter study in Japan. World J Surg 29:249–256PubMed

71.

Seeman T, Šimková E, Kreisinger J, Vondrák K, Dušek J, Gilík J, Dvorák P, Janda J (2007) Improved control of hypertension in children after renal transplantation: Results of a two-yr interventional trial. Pediatr Transplant 11:491–497PubMed

72.

Mitsnefes MM, Kimball TR, Border WL, Glascock BJ, Khoury PR, Daniels SR (2004) Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 43:721–726PubMed

73.

Kitzmueller E, Vécsei A, Pichler J, Bohm M, Muller T, Vargha R, Csaicsich D, Aufricht C (2004) Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol 19:1385–1389PubMed

74.

Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal diseases in children: a Dutch cohort study. Kidney Int 61:621–629

75.

Ruggenenti P, Perna A, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G (1993) Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 43:706–711

76.

Curtis JJ (1997) Treatment of hypertension in renal allograft patients: Does drug selection make a difference. Kidney Int 52(Suppl 63):S75–77

77.

Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001) Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study. Transplantation 72:107–111PubMed

78.

Stigant CE, Cohen J, Vivera M, Zaltzman JS (2000) ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis 35:58–63PubMed

79.

Arbeiter K, Pichler A, Stemberger R, Mueller T, Ruffingshofer D, Vargha R, Balzar E, Aufricht C (2004) ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol 19:222–226PubMed

80.

Ruggenenti P, Perna A, Gheradi G, Gaspari F, Benigni R, Remuzzi G (1998) Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet 352:1352–1356

81.

Tejani A, Sullivan EK (2000) The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 4:107–111PubMed

82.

Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF (2004) Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 19:2852–2857PubMed

83.

Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R (2006) Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17:889–899PubMed

84.

Opelz G, Zeier M, Laux G, Morath C, Dohler B (2006) No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A Collaborative Transplant Study report. J Am Soc Nephrol 17:3257–3262PubMed

85.

Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn KH (1999) ACE inhibitor versus β-blocker for the treatment of hypertension in renal allograft recipients. Hypertension 33:862–868PubMed

86.

Calvino J, Lens XM, Romero R, Sánchez-Guisande D (2000) Long-term anti-proteinuric effect of losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant 15:82–86PubMed

87.

Task force on cardiovascular disease (1998) Special report from the National Kidney Foundation. Am J Kidney Dis 32(Suppl 3):1–121

88.

Flynn JT (2006) Hypertension and future cardiovascular disease in pediatric renal transplant recipients. Pediatr Transplant 10:276–278PubMed

89.

Opelz G, Dohler B, Collaborative Transplant Study (2005) Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 5:2725–2731PubMed

90.

Groothoff JW, Cransberg K, Offringa M, Van De Kar NJ, Lilien MR, Davin JC, Heymans JS (2004) Long-term follow-up of renal transplantation in children: a Dutch cohort study. Transplantation 78:453–460

Title: Hypertension after renal transplantation
Author: Tomáš Seeman
Publication date: 01-05-2009
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 5/2009
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-007-0627-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Hypertension after renal transplantation

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2009

Chronic peritoneal dialysis in a 4-year-old boy with Lesch–Nyhan disease

Genotype–phenotype correlation in children with autosomal dominant polycystic kidney disease

Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome—a randomized prospective pilot trial

Measuring glomerular filtration rate in children; can cystatin C replace established methods? A review

Evolutive study of children with diffuse mesangial sclerosis

Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome